Literature DB >> 25480339

Comment on: "clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 Study)".

Richard Hoppe1, Tim Illidge2, Lena Specht3, Ivan Vogelius3, Joachim Yahalom4.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25480339      PMCID： PMC4257744          DOI： 10.1634/theoncologist.2014-0200

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  2 in total

1.  Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).

Authors:  Marta Bruno Ventre; Andrés J M Ferreri; Mary Gospodarowicz; Silvia Govi; Carlo Messina; David Porter; John Radford; Dae Seog Heo; Yeon Park; Giovanni Martinelli; Emma Taylor; Helen Lucraft; Angela Hong; Lydia Scarfò; Emanuele Zucca; David Christie
Journal:  Oncologist       Date:  2014-02-24

2.  Impact of rituximab and radiotherapy on outcome of patients with aggressive B-cell lymphoma and skeletal involvement.

Authors:  Gerhard Held; Samira Zeynalova; Niels Murawski; Marita Ziepert; Barbara Kempf; Andreas Viardot; Martin Dreyling; Michael Hallek; Mathias Witzens-Harig; Jochen Fleckenstein; Christian Rübe; Carsten Zwick; Bertram Glass; Norbert Schmitz; Michael Pfreundschuh
Journal:  J Clin Oncol       Date:  2013-09-23       Impact factor: 44.544
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.